Lynparza: Regulatory decision in US (based on PAOLA trial) for ovarian cancer in Q2 2020 (AstraZeneca) - Apr 29, 2020 - Q1 2020 Results: Regulatory decision in US for 2L prostate cancer in Q2 2020
sNDA • Genito-urinary Cancer • Gynecologic Cancers • Oncology • Ovarian Cancer • Prostate Cancer • Solid Tumor • Urothelial Cancer
|